GlassScriptPhysician profile
Tanuja Puri
NPI 1508023524
$4,455.60
in general payments reported to CMS, 2019-2025
19 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $496 · 2022: $771 · 2023: $997 · 2024: $796 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,415 · Travel and Lodging: $555 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,414.96 |
| Travel and Lodging | $554.93 |
| Education | $218.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,340.10 | 2021-2025 | |
| Janssen Biotech, INC. | $1,167.32 | 2022-2025 | Tremfya, Stelara |
| Intercept Pharmaceuticals, INC. | $156.10 | 2021-2023 | Ocaliva |
| Aimmune Therapeutics, INC. | $132.26 | 2024-2025 | Zenpep |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.48 | 2021-2022 | |
| Gilead Sciences, INC. | $77.35 | 2023 | |
| Nestle Healthcare Nutrition INC. | $61.59 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $59.67 | 2024-2025 | Voquezna |
| Ipsen Biopharmaceuticals, INC | $50.55 | 2024 | Bylvay, Iqirvo |
| Genzyme Corporation | $37.62 | 2023 | |
| Novo Nordisk INC | $26.31 | 2025 | Wegovy |
| Ferring Pharmaceuticals INC. | $24.66 | 2024 | Clenpiq |
| Intra-Sana Laboratories | $20.77 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Qol Medical, LLC | $20.69 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.68 | 2023 | Entyvio |
| Celgene Corporation | $15.59 | 2021 | |
| Merck Sharp & Dohme LLC | $13.83 | 2022 | |
| Pfizer INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanuja Puri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.